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http://dx.doi.org/10.1016/j.kjms.201Abstract Dysregulations of RNA A-to-I editing are associated with developmental defects in
mouse and human diseases. Although several methods of identifying RNA A-to-I editing sites
are currently available, most of the critical editing targets responsible for the important bio-
logical functions of adenosine deaminases that act on RNA (ADARs) remain unknown. Here we
report a modified I-specific cleavage method that improves the quality of the RNA product.
Preliminary microarray comparison of RNAs subjected to I-specific cleavage or mock digestion
reported 165 genes that showed more than 0.2-fold reductions due to the cleavage. Six of the
165 genes were randomly selected for further verification, and three were verified to be
targets of I-specific cleavage. This method may provide an alternative method of identifying
novel RNA A-to-I editing sites using a microarray and facilitate the inquiry into the roles of
RNA A-to-I editing in various biological processes.
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E13.5 because of a failure of erythropoiesis and wide-RNA adenosine-to-inosine (A-to-I) editing mediated by the
adenosine deaminase that acts on RNA (ADAR) protein
family is the most predominant form of single base editing
in the animal kingdom (Fig. 1A) [1e3]. ADAR1 and ADAR2
are ubiquitously expressed, whereas ADAR3 is only found in
the brain [4e6]. Because the base pairing property of I is
similar to G, RNA A-to-I editing has equivalent effects of
A-to-G mutations at the DNA level (Fig. 1B) [7]. Depending
on the position of the edited sequence, the effects of A-to-I
editing includes recoding of protein sequence, altering
splicing signals, changing RNA secondary structure and
stability, as well as the specificity of miRNAs [8].
A-to-I editing plays common and essential roles in the
normal biological processes such as neural transmission,
erythropoiesis, immune response, and energy metabo-
lism. The nervous system contains the highest inosine
content in brain mRNA and expresses the majority of the
known editing targets [9]. Gria2, which encodes an AMPA
(a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)
receptor subunit GluRB contains the most prevalent
editing site, the Q/R site. A-to-I editing of the Q/R site
recodes the glutamine in the pore-forming reentrant loop
to an arginine at greater than 99% efficiency [10]. The
editing of the Q/R site regulates targeting, unitary
conductance, and calcium permeability of AMPA recep-
tors, as well as the neuronal susceptibility to hypoxia-
induced excitotoxicity [11e14]. Lack of Q/R site editing
in ADAR2/ mice results in progressive seizures and
death shortly after birth [15]. Underediting of GluR2 in
spinal motor neurons was also found in human cases of
sporadic amyotrophic lateral sclerosis [16]. Htr2c encodes
the serotonin 5-HT2C receptor that contains five closely
spaced editing sites on the cytoplasmic loop interacting
with downstream G proteins [17]. The five editing sites
can recode three amino acids and affect the downstreamFigure 1. Identification of A-to-I editing target by I-specific clea
lyzes the deamination reaction that converts adenosine to inosine.
(C) The stable modification of guanidine with glyoxal and borate m
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Asignaling [18]. ADAR1/ knockout mouse embryos die at
spread apoptosis [19e21], probably due to unchecked
activation of the interferon pathway that induces
apoptosis of hematopoitic stem cells [22,23]. Endotoxin-
induced microvascular lung injury and systematic inflam-
mation dramatically increases ADAR1 expression, causing
5% of adenosines in the thymic mRNA to be edited to
inosines in the mouse [24,25]. ADAR2 expression is
increased by a high fat diet and reduced by fasting in the
pancreatic islets in mice [26]. Ubiquitous overexpression
of ADAR2 results in adult-onset hyperphagia-mediated
obesity [27].
Aberrant RNA A-to-I editing has also been implicated in
human diseases and cancer development. The altered
editing pattern of Htr2C greatly reduces serotonin
signaling in depression suicide victims [28]. ADAR1 muta-
tions have been found in human cases of dyscromatosis
symmetrica hereditaria [29,30]. Reduced A-to-I editing
activity has been reported in human brain, prostate,
kidney, and testis tumors [31]. A reduction in ADAR2
expression is strongly correlated with the malignancy of
glioblastoma multiforme [32]. Overexpression of ADAR
reduces the proliferation of astrocytoma cell lines [33],
but accelerates the cell cycle by up-regulating CDK2 in
HEK293 cells [34].
Deciphering these roles of RNA A-to-I editing depends on
the identification of the editing targets and the resulting
changes of protein functions. Experimental approaches
that can systematically identify and analyze novel A-to-I
editing sites will be necessary to elucidate their function
during development and disease. In 1997, Morse and Bass
[35] developed an I-specific cleavage method to cut the I-
containing mRNAs. Guanidine nucleotides are modified by
the formation of stable glyoxal/borate adducts and pro-
tected from RNase T1 digestion that recognizes both
guanidine and inosine residues under normal conditions
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Dvage. (A) ADAR (adenosine deaminase that acts on RNA) cata-
(B) A-to-I editing changes the original A:U pairing to I:C pairing.
akes guanidine resistant to RNase T1 digestion.
Microarray analysis of RNA A-to-I editing targets 181(Fig. 1C). Using differential display techniques to analyze
the RNA samples subjected to I-specific cleavage, Morse
and Bass [36] identified five and 19 new editing sites in
Caenorhabditis elegans and the human brain, respectively.
In this work, we report the result of a microarray anal-
ysis of RNAs subjected to a modified I-specific cleavage
method. Microarray comparison of RNAs subjected to I-
specific cleavage or mock digestion reported 165 genes that
showed more than 0.2-fold reductions due to the cleavage.
Six of the 165 genes were randomly selected for further
verification, and three were verified to be targets of I-
specific cleavage and therefore potential RNA A-to-I editing
targets. This result suggests that microarray analysis of I-
specifically cleaved RNA can be used to identify potential
RNA A-to-I editing genes.
Materials and methods
Mouse brain RNA
Brain total RNA was extracted from 1-month-old ICR mice.
The mouse brains were surgically removed and homoge-
nized in 10 volumes of Trizol by 20 strokes in a Dounce
homogenizer. Total RNA was then purified by following the
manufacturer’s instructions. An additional Trizol extraction
step was added in the end to remove any residual lipids or
proteins.
I-specific cleavage
Glyoxyl/borate modification
First, 10 mg of mouse brain RNA was glyoxylated in 100 mL of
10 mM sodium phosphate (pH 7.5), 50% dimethyl sulfoxide
(DMSO), and 0.6% deionized glyoxal at 37 C for 45 minutes.
The RNA was further modified with borate by mixing with
equal volume of 1 M sodium borate (pH 7.5) and precipi-
tated with 500 mL ethanol. The RNA was then redissolved in
15 mL of 1 M sodium borate buffered with 10 mM Tris (pH
7.5).
RNase T1 digestion and removal
RNase T1 (100 U for exon array and 1000 U for oligo and
expression array analysis) was added, and the nuclease
reaction was carried out at 37 C for 30 minutes. RNase T1
was then inactivated and removed by extraction with 10
volumes of Trizol. The resulting RNA pellet was dissolved in
400 mL nuclease-free water.
Glyoxal/borate removal
To remove borate as completely as possible, the RNA was
subjected to two rounds of NaOAc/ethanol precipitation at
room temperature. The centrifugation steps for ethanol
precipitation of RNA were carried out in a microcentrifuge
at 12 000 rpm for 15 minutes. To remove glyoxal, the RNA
pellet was resuspended in 400 mL of 10 mM sodium phos-
phate (pH 7.5) containing 50% DMSO and incubated at 60 C
for 2 hours, then precipitated by NaOAc/ethanol and dis-
solved in 10 mL of nuclease-free water ready for down-
stream application. Fifty to eighty percent of the starting
RNA was routinely recovered at the completion of I-specific
cleavage procedure.
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AVerification of I-specific cleavage on known editing
targets with RT-PCR
One-step reverse transcription-polymerase chain reaction
(RT-PCR) was performed using SuperScript III One-Step RT-PCR
System with Platinum Taq (Invitrogen) with 10 ng RNA
template. The primers designed to cover the editing sites in
known editing targets of mouse nervous system were as
follows: Gria2 forward, 50-TGGACTTATATGAGGAGTGCAG-30;
Gria2 reverse, 50-GGATGTAGAATACTCCAGCAAC-30; Htr2c
forward, 50-GTCCCTAGCCATTGCTGATATG-30; Htr2c reverse,
50-GCTTTCGTCCCTCAGTCCAATC-30; Kcna1 forward, 50-GGGT
CATCCGCTTGGTAAGG-30; Kcna1 reverse, 50-CACTATCGGCAA
TGAGCGGTTCC-30. Negative controls of I-specific cleavage
were: b-actin forward, 50-CACTATCGGCAATGAGCGGTTCC-30;
b-actin reverse, 50-TGCATCCTGTCAGCAATGCCTG-30 GAPDH
forward, 50-GCACAGTCAAGGCCGAGAAT-30; GAPDH reverse:
50-GCCTTCTCCATGGTGGTGAA-30.
Double-strand cDNA synthesis and amplification
Double-stranded cDNA was synthesized from 200 ng total
RNA and amplified using the Microarray Target Amplifica-
tion Kit (Roche). Briefly, first and second strand cDNA were
synthesized using the TAS-T7 Oligo(dT)24 primer and the
TAS-(dN)10 primer, respectively, resulting in ds-cDNA with
TAS tags on both ends. The ds-cDNA was purified using the
Microarray Target Purification Kit, and one-quarter of the
purified product was used as the template for a 100-mL PCR
reaction that underwent 21 cycles of amplification. The
amplified ds-cDNA was then again purified with the Micro-
array Target Purification Kit.
Microarray analysis
Probe preparation, hybridization, and image acquisition for
mouse expression arrays were carried out by the Affymetrix
GeneExpressionServiceLabofAcademicaSinica (http://ipmb.
sinica.edu.tw/affy/). Five micrograms of amplified ds-cDNA
with T7 tag was submitted for whole transcriptome analysis
using Mouse Gene Chip Array 430.2. Data normalization and
comparison of expression arrays were performed using DNA-
Chip Analyzer (dChip) [37]. Probe set annotations and gene
ontology information were retrieved from NetAffx Analysis
Center (http://www.affymetrix.com/analysis/index.affx).
Results
Glyoxal/borate modification of RNA
I-specific cleavage consists of three major steps: (1) modi-
fication of G with glyoxal and borate, (2) RNase T1 cleavage
of inosine, and (3) removal of RNase T1, borate, and
glyoxal. Because it involves high salt, heat, nuclease, and
lengthy incubation times, this process often compromises
the material for downstream applications.
To examine the status of the RNA during the process of
modification and the removal of glyoxal and borate,
aliquots of RNAs were removed at different steps of the
procedure and analyzed by electrophoresis. The starting
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28 s rRNAs (Fig. 2A, lane 1), which became single-stranded
and difficult to visualize by EtBr staining after being
denatured by glyoxal (Fig. 2A, lane 2). Total RNA modified
by both glyoxal and borate showed a slower migration
pattern, indicating increased molecular weight as a result
of modification (Fig. 2A, lane 3). The recovered RNA
showed smearing and trailing on agarose gel (Fig. 2A, lane
4) and failed as the template for one-step RT-PCR (data not
shown). To improve the quality of RNA, we enhanced the
removal of borate abducts from the modified RNA by adding
two rounds of ethanol precipitation carried out at room
temperature. The recovered RNA did not show signs of
smearing and trailing on agarose gel after this enhanced
removal of borate (Fig. 2B). The major bands of the rRNA
reappeared in roughly the same migration position but
diffused, likely due to the formation of random duplex
structures during renaturation.
I-specific cleavage
We then examined the change in RNA size distribution
caused by I-specific cleavage. The original step of removing
RNase T1 by proteinase K digestion followed by phenol/
chloroform extraction was replaced by one simple TrizolFigure 2. Glyoxal/borate modification of mouse brain total RN
modification procedure were analyzed by 1% agarose gel electroph
(B) the modified protocol. Lane 1: mouse brain total RNA; lane 2:
both glyoxal and borate; lane 4: total RNA after the removal of bo
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Aextraction. I-specific cleavage with 1000 U RNase T1 slightly
reduced the overall size of mouse brain mRNA compared to
control RNA with mock digestion, indicating that the
modification of G residues was effective and the removal of
RNase T1 by Trizol was complete (Fig. 3A). We routinely
recover 50e80% of the starting RNAs with both 260/280 and
260/230 ratios exceeding 1.9 using the modified I-specific
cleavage protocol.
The specific cleavage of known ADAR editing targets was
verified with one-step RT-PCR using primers designed to
cover the known editing site of each gene. After I-specific
cleavage, no RT-PCR products were detected in highly
edited genes such as Gria2 and Htr2c. In the case of Kcna1,
whose editing efficiency is lower, the band of the RT-PCR
product was weaker but still visible, whereas the b-actin
and GAPDH bands were unchanged after I-specific cleavage
(Fig. 3B). These results indicate that the RNase T1 cleavage
was specific to inosine-containing RNA, and the quality of
recovered RNA was sufficient for RT and PCR reactions.
Synthesis and amplification of double-strand cDNA
To ensure that the modified I-specific cleavage method
generated high-quality RNAs suitable formicroarray analysis,
we thencompared the lengthof thePCR-amplifiedcDNAs thatEDA. Aliquots of RNAs at different steps of the glyoxal/borate
oresis using (A) the original protocol described by Moss et al. or
total RNA denatured by glyoxal; lane 3: total RNA modified by
rate and glyoxal.
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Figure 3. I-specific cleavage of mouse brain total RNA and the synthesis and amplification of double-strand cDNA. (A) RNAse T1
cleavage of mouse brain RNA modified with glyoxal and borate. Agarose gel electrophoresis indicated that after I-specific cleavage
the size distribution was slightly lower. (B) Reverse transcription-polymerase chain reaction (RT-PCR) verification of I-specific
cleavage of known ADAR editing targets Gria2, Htr2c and Kcna1. RT-PCR was performed with primers designed to cover the known
editing sites. The three known A-to-I editing targets showed clear reduction of RT-PCR products after I-specific cleavage but not the
two housekeeping genes b-actin and GAPDH. The total RNA subjected to (C) the original I-specific cleavage protocol described by
Moss et al. or (D) the modified protocol was reverse transcribed by using T7-Poly(dT) oligomer and amplified by PCR. The size
distribution and the yield of the amplified cDNA showed clear improvement in the modified protocol.
ED
Microarray analysis of RNA A-to-I editing targets 183were reverse-transcribed from I-specifically cleaved RNA
prepared by the original and the modified protocols, respec-
tively. To facilitate the generation of aRNA probes for
microarray hybridization, the Poly(dT)24 oligomers tagged
with a T7 promoter sequence were used to prime the cDNA
synthesis. The yields of cDNAs generated from RNAs treated
with original I-specific cleavage protocol were lower, and the
cDNA fragment lengths were shorter than 1 kbp (Fig. 3C).
Using the modified protocol, both I-specifically cleaved RNA
and control, mock digestion RNA yielded ds-cDNAs that
showed similar even distributions between 300 bp and 3 kbp
(Fig. 3D). Taken together, these results indicate that the
modification of I-specific cleavage protocol improved the
quality of the RNA product, making it more compatible for
downstream molecular biology-based applications.
Analysis and preliminary verification of potential
editing targets
We then tested if the targets of I-specific cleavage can be
detected by expression microarray analysis. Brain RNA was
extracted from four female mice and subjected to I-specific
cleavage or mock digestion individually. Then T7-tagged ds-
cDNAs were synthesized as described above, and pooled
into two samples: one was subjected to I-specific cleavage
and the other to mock digestion. They were submitted to
the Affymetrix Gene Expression Service Lab of Academica
Sinica for whole transcriptome analysis using Affymetrix
Mouse Gene Chip Arrays 430.2. The data were normalized
and compared using dCHIP software [37]. A total of 165
genes (4 of them were identified twice by different probe
sets; Supplementary Table 1) were selected as potential
editing targets based on these criteria: showing more than
0.2-fold reductions (1.2-fold change) and a difference
R
E
R
A
larger than 700 in signal intensity after I-specific cleavage,
declared present before I-specific cleavage.
To verify the targets of I-specific cleavage identified by
this microarray screening, six of the 169 potential editing
targets (designated as ETs) were randomly selected for
preliminary verification using a strategy that did not require
sequencing the full length of cDNAs. The poly Aþ fragments
of I-specific cleavage products were first purified using an
mRNA purification kit and analyzed by one-step RT-PCR
using primers designed to amplify the 50-most region of
potential editing targets. The fragments 50 to the editing
site would be lost during the mRNA purification process
resulting in a reduction of RT-PCR templates in edited
genes (Fig. 4A). We observed varying degrees of reduction
of RT-PCR products after I-specific cleavage in all six
potential editing targets screened in this manner (Fig. 4B).
The densitometric analysis of results from replica experi-
ments using brain RNAs from four female mice showed that
three out of six potential editing targets showed a signifi-
cant reduction of RT-PCR products after I-specific cleavage
(Fig. 4C). This result suggests that microarray analysis of I-
specifically cleaved RNA can be used to identify potential
genes subject to RNA A-to-I editing.
Discussion
Experimental methods that can systematically identify
A-to-I editing target genes can greatly increase our under-
standing of the roles played by ADAR in biological processes
including stress response, synaptic transmission, metabolic
regulation, and tumorigenesis. Here, we report a modified
inosine-specific cleavage method that, in combination with
microarray analysis, allows for a systematic screening of
potential editing targets.
C
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Figure 4. Preliminary verification of potential editing targets identified by mouse expression microarray analysis. (A) To verify if
a gene is an editing target, the poly Aþ fragments are recovered after I-specific cleavage of total RNA and subjected to RT-PCR.
Primers (indicated by arrows) are designed to amplify near the 50-most regions as possible by one-step RT-PCR. I-specific cleavage
results in loss of fragments 50 to the editing site and reduction of the RT-PCR products. (B) Six potential editing targets (designated
as ETs) were randomly selected based on the analysis results using Mouse Gene Chip Array 430.2. These potential editing targets
showed different degrees of reduction of RT-PCR products after I-specific cleavage. (C) Densitometric analysis of these six editing
targets by using brain RNAs from four female mice. Three out of six potential editing targets showed significant reduction of RT-PCR
product after I-specific cleavage (mean  SD, *p < 0.05).R
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as judged by UV spectrometry and the efficiency for cDNA
synthesis. The downstream RT became more efficient,
generating cDNAs with a length of up to 3 kbp. RT-PCR
analyses indicated that the cleavage of RNase T1 on RNA
modified with glyoxal and borate was specific to inosine-
containing RNAs, cutting previously known editing targets
such as Gria2, 5HT2c, and Kcna1 but not b-actin or GAPDH.
The microarray comparison of RNAs subjected to I-specific
cleavage or mock digestion reported that 165 genes showed
more than 0.2-fold reductions due to the cleavage. Gene
ontology analysis showed that the major biological
processes that these genes participated in included cell
adhesion, cell cycle, metabolic process, RNA processing,
transcription, and transport. Six of the 165 genes were
R
ETrandomly selected for further verification, and three were
shown to be targets of I-specific cleavage and therefore
potential RNA A-to-I editing targets.
The sensitivity of detecting an inosine-containing site
could be influenced by several factors including editing
frequency, distance of the editing site to the probe set, and
degrees of RNase T1 digestion. The candidate genes iden-
tified by this microarray study are very likely edited in the
30 UTR. The probe sets of expression arrays are usually
designed to target the 30 regions of transcripts. Because the
hybridization probes of expression array are generated by
RT from the 30 end, RNAs that have been cut in the 50
regions would not show a significant reduction of the
hybridization signal in probe sets targeting regions 30 end of
the transcript. In fact, recoding of an amino acid sequence
Microarray analysis of RNA A-to-I editing targets 185by A-to-I editing only occurs in a small number of genes,
and most editing sites are found in noncoding regions [38].
In the expression array analysis of this study, out of the
total 45,101 probe sets, 35,726 (79.2%) were declared
marginal or absent in both arrays. The percentage of present
probe sets formock digestion and I-specific cleavage samples
was 16.4% and 16.2%, respectively. The 30/50 ratio of b-actin
and GAPDH was more than 20, indicating that the modified I-
specific cleavage protocol still resulted in certain degrees of
deterioration in RNA quality. Extension of cDNA synthesis to
the 50 end of mRNA was inefficient probably because of
random breaks in the mRNA or the incomplete removal of
modification. Further optimization of the I-specific cleavage
protocol may help to strike a balance between degrees of
modification, cleavage, and the quality of the RNA sample.
Possible improvements may also be made by using new
strategies of I-specific cleavage, for example, by developing
alternative methods of chemical modification of guanidine
that are efficient and can be easily removed, or by engi-
neering RNase T1 to redirect its specificity toward inosine.
RNase T1 has been shown to be amenable to directed
mutagenesis that alters its nucleotide specificity [39].
In summary, we have established a modified I-specific
cleavage method that improves the quality of the RNA
product. The preliminary analysis of the cleavage sites by
using expression microarray analysis has indentified 165
potential targets of I-specific cleavage. This method
provides an additional, alternative strategy to current
methods of identifying novel RNA A-to-I editing sites using
microarray [40] and will facilitate the inquiry into the roles
of RNA A-to-I editing in various biological processes.
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